Phase 1 evaluation of intralesionally injected TLR9-agonist PF-3512676 in patients with basal cell carcinoma or metastatic melanoma (Q42435785)
Jump to navigation
Jump to search
scientific article published on June 2008
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase 1 evaluation of intralesionally injected TLR9-agonist PF-3512676 in patients with basal cell carcinoma or metastatic melanoma |
scientific article published on June 2008 |
Statements
1 reference
Phase 1 evaluation of intralesionally injected TLR9-agonist PF-3512676 in patients with basal cell carcinoma or metastatic melanoma (English)
1 reference
Maja A Hofmann
1 reference
Christian Kors
1 reference
Heike Audring
1 reference
Peter Walden
1 reference
Wolfram Sterry
1 reference
Uwe Trefzer
1 reference
1 June 2008
1 reference
1 reference
Identifiers
1 reference